Northwest Biotherapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Northwest Biotherapeutics's estimated annual revenue is currently $1.7M per year.
- Northwest Biotherapeutics's estimated revenue per employee is $85,000
- Northwest Biotherapeutics's total funding is $169.4M.
Employee Data
- Northwest Biotherapeutics has 20 Employees.
- Northwest Biotherapeutics grew their employee count by 11% last year.
Northwest Biotherapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | SVP Business Development | Reveal Email/Phone |
3 | Chief Scientific Officer | Reveal Email/Phone |
4 | Chief Technical Officer | Reveal Email/Phone |
5 | Director Information Technology | Reveal Email/Phone |
6 | Office Manager | Reveal Email/Phone |
7 | Sr. Controller | Reveal Email/Phone |
Northwest Biotherapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.3M | 2 | -60% | N/A | N/A |
#2 | $2.9M | 38 | -31% | $17.5M | N/A |
#3 | $2.9M | 38 | -33% | $10.5M | N/A |
#4 | $19.8M | 128 | 0% | $69.4M | N/A |
#5 | $9.6M | 62 | -15% | N/A | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $7.4M | 48 | 0% | N/A | N/A |
#9 | $0.2M | 1 | -83% | N/A | N/A |
#10 | $1.7M | 11 | 22% | N/A | N/A |
What Is Northwest Biotherapeutics?
Northwest Biotherapeutics is developing two drug platforms -- DCVax and HuRx -- based on monoclonal antibodies. The company's patented monoclonal antibodies are designed to attach to cancer-causing antigens and kill cancer cells in cancers ranging from prostate and brain cancer to skin and breast cancer.
keywords:N/A$169.4M
Total Funding
20
Number of Employees
$1.7M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Northwest Biotherapeutics News
2022-04-19 - Ovarian Cancer Diagnostics Technologies Market Size ...
... Forecast | Adgero Biopharmaceuticals, Cellceutix, Roche, Natco Pharma, Northwest Biotherapeutics, Pfizer, Sumitomo Dainippon Pharma, VG Life Sciences.
2022-04-17 - Counsel Leadership Fight Looms In Pharma Co. Pay Suit
Northwest Biotherapeutics Inc. and the directors are represented by Raymond J. DiCamillo, Rudolf Koch, Alexander M. Krischik, and Sandy Xu of...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.8M | 20 | 33% | N/A |
#2 | $3.4M | 20 | -13% | N/A |
#3 | $5M | 20 | N/A | N/A |
#4 | $3.4M | 20 | 18% | N/A |
#5 | $2M | 20 | 5% | N/A |